(Q40549857)

21 September 2017

1 reference

title

Ceftazidime. An update of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy (English)

1 reference

21 September 2017

1 reference

C P Rains

1

1 reference

21 September 2017

H M Bryson

series ordinal

2

1 reference

21 September 2017

D H Peters

series ordinal

3

1 reference

21 September 2017

publication date

1 April 1995

1 reference

21 September 2017

1 reference

21 September 2017

volume

49

1 reference

21 September 2017

issue

4

1 reference

21 September 2017

page(s)

577-617

1 reference

The penetration of ceftazidime into peritoneal fluid in patients undergoing elective abdominal surgery

21 September 2017

cites work

1 reference

12 December 2020

Analysis of penicillinase-producing Neisseria gonorrhoeae isolates in Madrid (Spain) from 1983-85

1 reference

12 December 2020

Antibiotic susceptibility of streptococci isolated from blood from neutropenic patients

1 reference

12 December 2020

Controlled trial of ceftazidime vs. ticarcillin and tobramycin in the treatment of acute respiratory exacerbations in patients with cystic fibrosis

1 reference

12 December 2020

Double-blind, prospective, multicenter trial comparing ceftazidime with moxalactam in the treatment of serious gram-negative infections

1 reference

12 December 2020

Relation of structural properties of beta-lactam antibiotics to antibacterial activity.

1 reference

12 December 2020

Evaluation of new anti-infective drugs for the treatment of febrile episodes in neutropenic patients. Infectious Diseases Society of America and the Food and Drug Administration

1 reference

12 December 2020

Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model

1 reference

12 December 2020

Pharmacokinetics of ceftazidime in elderly volunteers

1 reference

12 December 2020

Empiric antimicrobial therapy with aztreonam or ceftazidime in gram-negative septicemia.

1 reference

12 December 2020

Fluoroquinolone antimicrobial agents

1 reference

12 December 2020

Antimicrobial activity of E-1040, a novel thiadiazolyl cephalosporin compared with other parenteral cephems

1 reference

12 December 2020

Aerosol antibiotic treatment in cystic fibrosis

1 reference

12 December 2020

Pefloxacin versus ceftazidime in therapy of soft tissue infections in compromised patients

1 reference

12 December 2020

Oral ciprofloxacin: a pharmacoeconomic evaluation of its use in the treatment of serious infections

1 reference

12 December 2020

Acinetobacter in Denmark: I. Taxonomy, antibiotic susceptibility, and pathogenicity of 112 clinical strains

1 reference

12 December 2020

Lomefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

1 reference

12 December 2020

Comparative in vitro antibacterial activity of aztreonam against clinical isolates of gram-negative bacteria

1 reference

12 December 2020

Use of ceftazidime in the treatment of osteomyelitis and osteoarthritis

1 reference

12 December 2020

Comparison of ceftazidime with cefamandole for therapy of community-acquired pneumonia

1 reference

12 December 2020

Major trends in the microbial etiology of nosocomial infection.

1 reference

12 December 2020

A Comparison of Imipenem to Ceftazidime With or Without Amikacin as Empiric Therapy in Febrile Neutropenic Patients

1 reference

12 December 2020

Treatment of skin, skin structure, bone, and joint infections with ceftazidime

1 reference

12 December 2020

Multiple-dose pharmacokinetics of amikacin and ceftazidime in critically ill patients with septic multiple-organ failure during intermittent hemofiltration

1 reference

12 December 2020

[Structure-activity relationship of ceftazidime. Consequences on the bacterial spectrum]

1 reference

12 December 2020

Penetration of cefuroxime and ceftazidime into human lungs

1 reference

12 December 2020

Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia

1 reference

12 December 2020

Pharmacokinetics of ceftazidime in acutely ill hospitalised elderly patients

1 reference

12 December 2020

Ceftazidime or amikacin: choice of intravitreal antimicrobials in the treatment of postoperative endophthalmitis

1 reference

12 December 2020

Novel plasmid-mediated beta-lactamase in clinical isolates of Klebsiella pneumoniae more resistant to ceftazidime than to other broad-spectrum cephalosporins

1 reference

12 December 2020

In vitro activity and beta-lactamase stability of FK-037, a parenteral cephalosporin

1 reference

12 December 2020

Randomized comparison of cefepime and ceftazidime for treatment of skin, surgical wound, and complicated urinary tract infections in hospitalized subjects

1 reference

12 December 2020

Post-antibiotic effect of ceftazidime, ciprofloxacin, imipenem, piperacillin and tobramycin for Pseudomonas cepacia

1 reference

12 December 2020

Comparative toxicities of third-generation cephalosporins

1 reference

12 December 2020

Antibiotic-associated hypoprothrombinemia: a review of prospective studies, 1966-1988.

1 reference

12 December 2020

A comparative study of cefepime for bacterial pneumonia

1 reference

12 December 2020

Ceftazidime versus imipenem-cilastatin as initial monotherapy for febrile neutropenic patients

1 reference

12 December 2020

Safety of parenteral third-generation cephalosporins

1 reference

12 December 2020

A randomized trial of cefepime (BMY-28142) and ceftazidime for the treatment of pneumonia

1 reference

12 December 2020

A comparative study of cefepime and ceftazidime in the treatment of community-acquired lower respiratory tract infections

1 reference

12 December 2020

Continuous infusion of beta-lactam antibiotics

1 reference

12 December 2020

Meeting the challenges of beta-lactamases

1 reference

12 December 2020

Beta-lactam-resistant Enterobacter bacteremia in febrile neutropenic patients receiving monotherapy

1 reference

12 December 2020

Comparative in vitro activity of FK-037, a new cephalosporin antibiotic

1 reference

12 December 2020

A comparison of aztreonam and ceftazidime in the treatment of respiratory infections in adults with cystic fibrosis

1 reference

12 December 2020

Home versus hospital intravenous antibiotic therapy in the treatment of young adults with cystic fibrosis

1 reference

12 December 2020

[Pharmacokinetic and clinical studies of ceftazidime in perinatal period]

1 reference

12 December 2020

Interactions of ceftibuten with extended-spectrum beta-lactamases: a bacteriological and enzymatic analysis

1 reference

12 December 2020

Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States, I. Study on the threat of emerging resistances: real or perceived? Fluoroquinolone Resistance Surveillance Group.

1 reference

12 December 2020

Ceftazidime in the elderly: appropriateness of twice-daily dosing

1 reference

12 December 2020

Photosensitivity due to ambulatory intravenous ceftazidime in cystic fibrosis patient

1 reference

12 December 2020

Comparative efficacy of ceftazidime vs. carbenicillin and amikacin for treatment of neonatal septicemia

1 reference

12 December 2020

Antibacterial activity of cefepime in vitro.

1 reference

12 December 2020

Ceftazidime vs. amoxicillin/clavulanate in the treatment of severe melioidosis

1 reference

12 December 2020

Populations at risk for penicillin-induced seizures

1 reference

12 December 2020

In vitro and in vivo antibacterial activities of FK037, a novel parenteral broad-spectrum cephalosporin

1 reference

12 December 2020

Neurotoxicity associated with ceftazidime therapy in geriatric patients with renal dysfunction

1 reference

12 December 2020

Dangers of oral fluoroquinolone treatment in community acquired upper respiratory tract infections

1 reference

12 December 2020

Ceftazidime-induced encephalopathy in a patient with renal impairment

1 reference

12 December 2020

New insights into the activity of third-generation cephalosporins against pneumonia-causing bacteria

1 reference

12 December 2020

Multicenter prospective randomized trial comparing ceftazidime plus co-trimoxazole with chloramphenicol plus doxycycline and co-trimoxazole for treatment of severe melioidosis

1 reference

12 December 2020

Relationship of ceftazidime pharmacokinetic indices with therapeutic outcome in patients with cystic fibrosis

1 reference

12 December 2020

Catheter-associated sepsis due to Alcaligenes xylosoxidans in a child with AIDS

1 reference

12 December 2020

Antimicrobial activity of cefepime tested against Bush group I beta-lactamase-producing strains resistant to ceftazidime. A multilaboratory national and international clinical isolate study.

1 reference

12 December 2020

Penetration of ceftazidime into human pancreas

1 reference

12 December 2020

Ceftazidime-induced hemolysis in a patient with drug-dependent antibodies reactive by immune complex and drug adsorption mechanisms

1 reference

12 December 2020

Cost comparison of ceftazidime versus tobramycin/ticarcillin therapy in three hospitals

1 reference

12 December 2020

[A comparative study between cefpirome (CPR) and ceftazidime (CAZ) in respiratory tract infections]

1 reference

12 December 2020

Randomized comparison between two ceftazidime-containing regimens and cephalothin-gentamicin-carbenicillin in febrile granulocytopenic cancer patients

1 reference

12 December 2020

Cefpirome: efficacy in the treatment of urinary and respiratory tract infections and safety profile

1 reference

12 December 2020

Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics

1 reference

12 December 2020

Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing beta-lactamases in a single isolate

1 reference

12 December 2020

Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients

1 reference

12 December 2020

The renal clearance of cefuroxime and ceftazidime and the effect of probenecid on their tubular excretion

1 reference

12 December 2020

Ceftazidime Monotherapy for Empiric Treatment of Febrile Neutropenic Patients: A Metaanalysis

1 reference

12 December 2020

Truncal asterixis associated with ceftazidime, a third-generation cephalosporin

1 reference

12 December 2020

Ceftazidime in middle ear fluid

1 reference

12 December 2020

Pharmacokinetics of ceftazidime in adult cystic fibrosis patients during continuous infusion and ambulatory treatment at home.

1 reference

12 December 2020

Imipenem/cilastatin. A reappraisal of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy

1 reference

12 December 2020

In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin.

1 reference

12 December 2020

Pharmacokinetics of ceftazidime in patients with liver cirrhosis and ascites

1 reference

12 December 2020

Klebsiella pneumoniae bacteraemia at an urban general hospital

1 reference

12 December 2020

Thrombocytopenia possibly caused by structurally related third-generation cephalosporins

1 reference

12 December 2020

Comparison of two antibiotic regimens (piperacillin plus amikacin versus ceftazidime plus amikacin) as empiric therapy for febrile neutropenic patients with cancer

1 reference

12 December 2020

Ceftazidime disposition in acute and stable cystic fibrosis

1 reference

12 December 2020

Sequential intravenous-oral administration of ciprofloxacin vs ceftazidime in serious bacterial respiratory tract infections

1 reference

12 December 2020

Comparative in vitro activity of amoxycillin/clavulanate (augmentin), ceftazidime and ceftriaxone against hospital strains of gram-negative and -positive bacteria

1 reference

12 December 2020

Ciprofloxacin plus vancomycin versus ceftazidime plus gentamicin in the treatment of pneumonia in granulocytopenic patients with or without venous catheters. Short communication

1 reference

12 December 2020

Agranulocytosis associated with cephalosporin

1 reference

12 December 2020

Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. The International Antimicrobial Therapy Cooperative Group of t

1 reference

12 December 2020

Monotherapy in serious hospital-acquired infections: a clinical trial of ceftazidime versus imipenem/cilastatin. European Study Group.

1 reference

12 December 2020

Ceftazidime monotherapy vs. combined therapy in Pseudomonas pulmonary infections in cystic fibrosis.

1 reference

12 December 2020

Comparative, double-blind study of intravenous ciprofloxacin and intravenous ceftazidime in serious infection

1 reference

12 December 2020

Intravenous fleroxacin versus ceftazidime in the treatment of acute nonpneumococcal lower respiratory tract infections

1 reference

12 December 2020

Beta-lactam regimens for the febrile neutropenic patient

1 reference

12 December 2020

Ceftazidime encephalopathy: absence status and toxic hallucinations

1 reference

12 December 2020

A prospective, randomized comparison of ceftazidime and ciprofloxacin as initial empiric therapy in neutropenic patients with fever

1 reference

12 December 2020

Pemphigus erythematosus induced by ceftazidime

1 reference

12 December 2020

Management of fever in patients with cancer and treatment-induced neutropenia

1 reference

12 December 2020

Comparative study of five plasmid-mediated ceftazidimases isolated in Klebsiella pneumoniae.

1 reference

12 December 2020

A randomised comparison of ceftazidime and piperacillin, both in combination with flucloxacillin for treatment of febrile episodes in neutropenic children. Finnish Three-Centre Study

1 reference

12 December 2020

A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia

1 reference

12 December 2020

Malignant external otitis: report on therapy with ceftazidime and review of therapy and prognosis

1 reference

12 December 2020

Failure of ceftazidime-amikacin therapy for bacteremia and meningitis due to Klebsiella pneumoniae producing an extended-spectrum beta-lactamase

1 reference

12 December 2020

Endotracheal and aerosol administrations of ceftazidime in patients with nosocomial pneumonia: pharmacokinetics and absolute bioavailability

1 reference

12 December 2020

Prospective evaluation of risk factors for antibiotic-associated bleeding in critically ill patients

1 reference

12 December 2020

Pharmacotherapeutic consequences of recent advances in hemodialysis therapy

1 reference

12 December 2020

Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem

1 reference

12 December 2020

[Clinical and laboratory evaluations of ceftazidime in perinatal use. A study of ceftazidime in the perinatal co-research group]

1 reference

12 December 2020

Ofloxacin versus parenteral therapy for chronic osteomyelitis

1 reference

12 December 2020

Susceptibilities of 177 penicillin-susceptible and -resistant pneumococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem, and vancomycin

1 reference

12 December 2020

Sequential intravenous and oral ciprofloxacin versus intravenous ceftazidime in the treatment of complicated urinary tract infections

1 reference

12 December 2020

Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group

1 reference

12 December 2020

Ceftazidime for therapy of children with chronic suppurative otitis media without cholesteatoma

1 reference

12 December 2020

Ceftazidime versus ceftazidime plus tobramycin in febrile neutropenic children

1 reference

12 December 2020

Pharmacokinetics and tissue concentrations of ceftazidime in burn patients

1 reference

12 December 2020

The effect of obstruction on the biliary excretion of cefoperazone and ceftazidime

1 reference

12 December 2020

In-vitro antibacterial activity of DQ-2556 and its stability to various beta-lactamases.

1 reference

12 December 2020

A multicentre study of the in-vitro activity of cefotaxime, cefuroxime, ceftazidime, ofloxacin and ciprofloxacin against blood and urinary pathogens.

1 reference

12 December 2020

Medical management of chronic suppurative otitis media without cholesteatoma in children

1 reference

12 December 2020

Pharmacokinetics of ceftazidime and ceftriaxone and their penetration into the ascitic fluid

1 reference

12 December 2020

Comparative in-vitro activity of piperacillin-tazobactam against recent clinical isolates, a Dutch national multicentre study.

1 reference

12 December 2020

Ceftazidime in the treatment of nosocomial sepsis

1 reference

12 December 2020

A randomized clinical trial of ceftriaxone and teicoplanin versus ceftazidime and teicoplanin as antibiotic therapy in febrile neutropenic cancer patients and bone marrow transplant recipients

1 reference

12 December 2020

Intraocular ceftazidime as an alternative to the aminoglycosides in the treatment of endophthalmitis

1 reference

12 December 2020

Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins

1 reference

12 December 2020

Ceftazidime Monotherapy for Pulmonary Melioidosis in a Traveler Returning from Thailand

1 reference

12 December 2020

Ceftriaxone and Amikacin versus Ceftazidime and Amikacin in Febrile Granulocytopenia

1 reference

12 December 2020

Drug treatment of pneumonia in the elderly: efficacy and costs

1 reference

12 December 2020

Pharmacokinetics of ceftazidime in elderly patients

1 reference

12 December 2020

Randomized evaluation of ceftazidime or ticarcillin and tobramycin for the treatment of osteomyelitis caused by gram-negative bacilli

1 reference

12 December 2020

Relapse in melioidosis: incidence and risk factors

1 reference

12 December 2020

Bacterial multidrug resistance--emphasis on efflux mechanisms and Pseudomonas aeruginosa

1 reference

12 December 2020

In vitro activity of Ro 23-9424, ceftazidime, and eight other newer beta-lactams against 100 gram-positive blood culture isolates

1 reference

12 December 2020

Canadian survey of antimicrobial resistance in Klebsiella spp. and Enterobacter spp. The Canadian Antimicrobial Resistance Study Group

1 reference

12 December 2020

In vitro activity of FK-037, a novel parenteral cephalosporin, against bacterial isolates from neutropenic cancer patients.

1 reference

12 December 2020

Penetration of ceftazidime into the human prostate gland following intravenous injection

1 reference

12 December 2020

Decreased susceptibility of penicillin-resistant pneumococci to twenty-four beta-lactam antibiotics

1 reference

12 December 2020

Economic evaluation of oral ofloxacin versus standard parenteral therapy in the treatment of pneumonia

1 reference

12 December 2020

Dosage adjustment for ceftazidime in patients with impaired renal function

1 reference

12 December 2020

[Comparative study of cefpirome and ceftazidime in complicated urinary tract infections]

1 reference

12 December 2020

Quinolones in perspective

1 reference

12 December 2020

Comparison of intravenous fleroxacin with ceftazidime for treatment of complicated urinary tract infections.

1 reference

12 December 2020

Comparative study of a novel plasmid-mediated beta-lactamase, CAZ-2, and the CTX-1 and CAZ-1 enzymes conferring resistance to broad-spectrum cephalosporins

1 reference

12 December 2020

Comparative clinical, microbiologic, and economic audit of the use of oral ciprofloxacin and parenteral antimicrobials

1 reference

12 December 2020

Single- and multiple-dose pharmacokinetics of ceftazidime in infected patients with varying degrees of renal function

1 reference

12 December 2020

Pseudomonas pseudomallei, a common pathogen in Thailand that is resistant to the bactericidal effects of many antibiotics

1 reference

12 December 2020

Cure of Pseudomonas aeruginosa infection in neutropenic patients by continuous infusion of ceftazidime

1 reference

12 December 2020

Penetration of ceftazidime into intracranial abscess

1 reference

12 December 2020

A comparison of the cost of ceftazidime therapy and gentamicin combinations in three UK hospitals

1 reference

12 December 2020

Ceftazidime therapy versus aminoglycoside therapy in patients with gram-negative burn wound infections

1 reference

12 December 2020

Randomized prospective study of ceftazidime versus ceftazidime plus cephalothin in empiric treatment of febrile episodes in severely neutropenic patients

1 reference

12 December 2020

[Fundamental and clinical evaluation of ceftazidime in perinatal studies]

1 reference

12 December 2020

A comparison of ceftazidime and aminoglycoside based regimens as empirical treatment in 1316 cases of suspected sepsis in the newborn. European Society for Paediatric Infectious Diseases--Neonatal Sepsis Study Group.

1 reference

12 December 2020

Ceftazidime versus tobramycin plus ticarcillin in the treatment of soft-tissue infections

1 reference

12 December 2020

[Fundamental and clinical studies on ceftazidime in pediatric surgery]

1 reference

12 December 2020

Nosocomial outbreaks of multiresistant bacteria: extended-spectrum beta-lactamases have arrived in North America

1 reference

12 December 2020

Cefepime compared with ceftazidime as initial therapy for serious bacterial infections and sepsis syndrome

1 reference

12 December 2020

Gram-positive bacteraemia in granulocytopenic cancer patients

1 reference

12 December 2020

Comparative antimicrobial activity of FK037, cefpirome, ceftazidime and cefepime against aminoglycoside-sensitive and aminoglycoside-resistant Pseudomonas aeruginosa and Pseudomonas spp.

1 reference

12 December 2020

Antagonism of ceftazidime by chloramphenicol in vitro and in vivo during treatment of gram negative meningitis

1 reference

12 December 2020

Comparative pharmacokinetics of ceftazidime in young, healthy and elderly, acutely ill males

1 reference

12 December 2020

A randomised dosage study of ceftazidime with single daily tobramycin for the empirical management of febrile neutropenia in patients with hematological diseases

1 reference

12 December 2020

[Fundamental and clinical studies on ceftazidime in the perinatal period]

1 reference

12 December 2020

Penetration of ceftazidime into intracranial abscess

1 reference

12 December 2020

Hallucinations in association with ceftazidime

1 reference

12 December 2020

Institutional formularies: the relevance of pharmacoeconomic analysis to formulary decisions

1 reference

12 December 2020

Penetration of ceftazidime into bronchial secretions in critically ill patients

1 reference

12 December 2020

Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae

1 reference

12 December 2020

Ceftazidime as first-line therapy for fever in acute leukaemia

1 reference

12 December 2020

Advancing age and acute infection influence the kinetics of ceftazidime

1 reference

12 December 2020

Ceftazidime treatment of chronic Pseudomonas infection in patients with cystic fibrosis

1 reference

12 December 2020

Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility

1 reference

12 December 2020

Multicenter evaluation of the in vitro activity of piperacillin-tazobactam compared with eleven selected beta-lactam antibiotics and ciprofloxacin against more than 42,000 aerobic gram-positive and gram-negative bacteria. In Vitro Susceptibility Sur

1 reference

12 December 2020

Comparative in vitro activity of lomefloxacin and other antimicrobials against 597 microorganisms causing bacteremia.

1 reference

12 December 2020

Immediate and prolonged clinical efficacy of ceftazidime versus ceftazidime plus tobramycin in chronic Pseudomonas aeruginosa infection in cystic fibrosis

1 reference

12 December 2020

Does monotherapy of pulmonary infections in cystic fibrosis lead to early development of resistant strains of Pseudomonas aeruginosa?

1 reference

12 December 2020

Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases

1 reference

12 December 2020

Empirical antimicrobial therapy in the neutropenic host

1 reference

12 December 2020

Susceptibilities of 200 penicillin-susceptible and -resistant pneumococci to piperacillin, piperacillin-tazobactam, ticarcillin, ticarcillin-clavulanate, ampicillin, ampicillin-sulbactam, ceftazidime, and ceftriaxone

1 reference

12 December 2020

Cefepime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

1 reference

12 December 2020

1 reference

12 December 2020

Post-antibiotic effect of FK-037 and biapenem tested against five bacterial species.

1 reference

12 December 2020

Kinetics of ceftazidime during plasmapheresis

1 reference

12 December 2020

A case of ceftazidime-induced pneumonitis

1 reference

12 December 2020

Pharmacoeconomic analysis of empirical therapy with ceftazidime alone or combination antibiotics for febrile neutropenia in cancer patients

1 reference

12 December 2020

Ocular penetration of ceftriaxone, ceftazidime, and vancomycin after subconjunctival injection in humans

1 reference

12 December 2020

Pharmacokinetics of ceftazidime and netilmicin in patients with sepsis

1 reference

12 December 2020

Infectious complications of neoplastic disease

1 reference

12 December 2020

Pseudomonas aeruginosa outbreak in a burn unit: role of antimicrobials in the emergence of multiply resistant strains

1 reference

12 December 2020

Ceftazidime Plus Amikacin Versus Ceftazidime Plus Vancomycin as Empiric Therapy in Febrile Neutropenic Children with Cancer

1 reference

12 December 2020

Imipenem compared with ceftazidime plus vancomycin as initial therapy for fever in neutropenic children with cancer

1 reference

12 December 2020

Oral antimicrobial therapy for osteomyelitis

1 reference

12 December 2020

CSF pharmacokinetics of ceftazidime in neurosurgical patients with an external ventriculostomy

1 reference

12 December 2020

International comparative study of cefepime and ceftazidime in the treatment of serious bacterial infections

1 reference

12 December 2020

In vitro activity of cefpirome against beta-lactamase-inducible and stably derepressed Enterobacteriaceae.

1 reference

12 December 2020

Halving of mortality of severe melioidosis by ceftazidime

1 reference

12 December 2020

Amikacin plus piperacillin versus ceftazidime as initial therapy in granulocytopenic patients with presumed bacteremia

1 reference

12 December 2020

A randomized prospective study of ceftazidime versus ceftazidime plus flucloxacillin in the empiric treatment of febrile episodes in severely neutropenic patients

1 reference

12 December 2020

Current antibacterial therapy for neonatal sepsis and meningitis

1 reference

12 December 2020

An outbreak of multiresistant Klebsiella in a neonatal intensive care unit

1 reference

12 December 2020

In vitro activity of aztreonam, cefuroxime and ceftazidime against gram-negative rods isolated from hospital patients with urinary tract infection.

1 reference

12 December 2020

Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone

1 reference

12 December 2020

Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae

1 reference

12 December 2020

Antibiotic concentrations in the groin wound after vascular prosthetic implantation

1 reference

12 December 2020

The beta-lactamases of gram-negative bacteria and their role in resistance to beta-lactam antibiotics

1 reference

12 December 2020

Outpatient management of chronic suppurative otitis media without cholesteatoma in children

1 reference

12 December 2020

Transduction of resistance to Imipenem, Aztreonam and Ceftazidime in nosocomial strains of Pseudomonas aeruginosa by wild-type phages

1 reference

12 December 2020

Penicillin, ceftazidime, and the epilepsies

1 reference

12 December 2020

Comparative clinical trial of ceftazidime and imipenem/cilastatin in patients with severe nosocomial pneumonias and septicaemias

1 reference

12 December 2020

[A study on ceftazidime in the perinatal period]

1 reference

12 December 2020

Systemic antimicrobial therapy for skin and skin structure infections: comparison of fleroxacin and ceftazidime

1 reference

12 December 2020

Cost-effectiveness comparison of cefepime and ceftazidime using decision analysis

1 reference

12 December 2020

Randomized study of intravenous/oral ciprofloxacin versus ceftazidime in the treatment of hospital and nursing home patients with lower respiratory tract infections

1 reference

12 December 2020

In vitro antibacterial activity of FK037, a new parenteral broad-spectrum cephalosporin, against recent clinical isolates in the fields of obstetrics and gynecology.

1 reference

12 December 2020

The optimal dosage of ceftazidime for severe lower respiratory tract infections

1 reference

12 December 2020

Safety and pharmacokinetics of ceftazidime in patients with chronic hepatic dysfunction

1 reference

12 December 2020

Efficacy of ceftazidime in chronic melioidosis with multiple liver abscesses

1 reference

12 December 2020

Identification of TEM-26 beta-lactamase responsible for a major outbreak of ceftazidime-resistant Klebsiella pneumoniae

1 reference

12 December 2020

Comparative Efficacy of Ceftriaxone versus Ceftazidime in the Treatment of Nosocomial Lower Respiratory Tract Infections

1 reference

12 December 2020

A comparison of the costs of ceftazidime therapy and gentamicin combinations in three UK hospitals

1 reference

12 December 2020

Ceftazidime concentration in gallbladder tissue and excretion in bile

1 reference

12 December 2020

Fundamental and clinical evaluation of ceftazidime in the perinatal period

1 reference

12 December 2020

Cefoperazone versus ceftazidime monotherapy of nosocomial pneumonia

1 reference

12 December 2020

A randomised trial of empirical antibiotic therapy in febrile neutropenic patients with hematological disorders: ceftazidime versus azlocillin plus amikacin

1 reference

12 December 2020

Effects of ceftazidime, a betalactam antibiotic, on murine haemopoiesis in vitro

1 reference

12 December 2020

Outbreak of infection in two UK hospitals caused by a strain of Klebsiella pneumoniae resistant to cefotaxime and ceftazidime

1 reference

12 December 2020

Ceftazidime in neonatal infections

1 reference

12 December 2020

Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum beta-lactamases

1 reference

12 December 2020

Neurotoxicity of β-lactam antibiotics: predisposing factors and pathogenesis

1 reference

12 December 2020

The current and future impact of antimicrobial resistance among nosocomial bacterial pathogens

1 reference

12 December 2020

Efficacy and tolerability of imipenem-cilastatin versus ceftazidime plus tobramycin as empiric therapy of presumed bacterial infection in neutropenic cancer patients

1 reference

12 December 2020

Intravenous and oral ciprofloxacin versus intravenous ceftazidime for the treatment of severe urinary tract infections

1 reference

12 December 2020

Ceftazidime monotherapy vs. ceftriaxone/tobramycin for serious hospital-acquired gram-negative infections. Antibiotic Study Group.

1 reference

12 December 2020

Pharmacokinetics of intravenous and intraperitoneal ceftazidime in chronic ambulatory peritoneal dialysis

1 reference

12 December 2020

Parenteral ciprofloxacin compared with ceftazidime in the treatment of serious upper and lower urinary tract infection

1 reference

12 December 2020

Beta-lactamase inhibitors and reversal of antibiotic resistance

1 reference

12 December 2020

Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

1 reference

12 December 2020

Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study

1 reference

12 December 2020

Pharmacokinetics of cefuroxime and ceftazidime in patients with acute renal failure treated by continuous arteriovenous haemodialysis

1 reference

12 December 2020

Retrospective clinical study of hypersensitivity reactions to aztreonam and six other beta-lactam antibiotics in cystic fibrosis patients receiving multiple treatment courses

1 reference

12 December 2020

Penetration of ceftazidime into the cerebrospinal fluid of patients with and without evidence of meningeal inflammation

1 reference

12 December 2020

Successful treatment with ceftazidime of a Pseudomonas fluorescens chest infection in a myasthenic patient

1 reference

12 December 2020

Comparison of pefloxacin with ceftazidime in severe bronchopulmonary infections

1 reference

12 December 2020

A comparative study of cefepime for chronic respiratory tract infections

1 reference

12 December 2020

Ceftazidime as monotherapy or combined with teicoplanin for initial empiric treatment of presumed bacteremia in febrile granulocytopenic patients

1 reference

12 December 2020

Cefotaxime. An update of its pharmacology and therapeutic use.

1 reference

12 December 2020

Ceftazidime treatment in severe burns. Serious infections in patients with severe burns treated with ceftazidime

1 reference

12 December 2020

Ceftazidime with or without vancomycin vs. cephalothin, carbenicillin and gentamicin as the initial therapy of the febrile neutropenic pediatric cancer patient.

1 reference

12 December 2020

Adverse effects of newer cephalosporins. An update

1 reference

12 December 2020

Controlling the costs of antibiotic resistance.

1 reference

12 December 2020

Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Canc

1 reference

12 December 2020

Influence of the glomerular filtration rate on renal clearance of ceftazidime in cystic fibrosis

1 reference

12 December 2020

Altohyrtins B and C and 5-desacetylaltohyrtin A, potent cytotoxic macrolide congeners of altohyrtin A, from the Okinawan marine sponge Hyrtios altum

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.41.989

Identifiers

DOI

10.2165/00003495-199549040-00008

1 reference

Dimensions Publication ID

21 September 2017

1001641682

0 references

1 reference